United States · FDA National Drug Code directory
SEGLUROMET
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-5373_208233c5-c2da-4374-bb1d-e71ea3a90028
- Product NDC
- 0006-5373
- Form
- TABLET, FILM COATED
- Composition / generic term
- ertugliflozin and metformin hydrochloride
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20171219
- Source listing expiry
- 20271231
Source-listed ingredients
- ERTUGLIFLOZIN PIDOLATE — 2.5 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (0006-5373-03) · 0006-5373-03
- 180 TABLET, FILM COATED in 1 BOTTLE (0006-5373-06) · 0006-5373-06
- 500 TABLET, FILM COATED in 1 BOTTLE (0006-5373-07) · 0006-5373-07
- 2 BOTTLE in 1 CARTON (0006-5373-09) / 14 TABLET, FILM COATED in 1 BOTTLE (0006-5373-08) · 0006-5373-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →